Amyris
AMYRIS, INC. (Form: 3, Received: 09/27/2010 20:36:23)
FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: February 28, 2011
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

DOERR L JOHN

2. Date of Event Requiring Statement (MM/DD/YYYY)
9/27/2010 

3. Issuer Name and Ticker or Trading Symbol

AMYRIS, INC. [AMRS]

(Last)        (First)        (Middle)

C/O KLEINER PERKINS CAUFIELD & BYERS, 2750 SAND HILL ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                            _____ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

MENLO PARK, CA 94025       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   5022   I   (1) By Clarus, LLC   (1)
Common Stock   129953   I   (2) By Kleiner Perkins Caufield & Byers XII, LLC   (2)
Common Stock   1655   I   (3) By KPCB XII Founders Fund, LLC   (3)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Preferred Stock     (4)   (4) Common Stock   119339   (4) $0.00   I   (1) By Clarus, LLC   (1)
Series A Preferred Stock     (4)   (4) Common Stock   3068996   (4) $0.00   I   (2) By Kleiner Perkins Caufield & Byers XII, LLC   (2)
Series A Preferred Stock     (4)   (4) Common Stock   58648   (4) $0.00   I   (3) By KPCB XII Founders Fund, LLC   (3)
Series B Preferred Stock     (5)   (5) Common Stock   5214   (5) $0.00   I   (1) By Clarus, LLC   (1)
Series B Preferred Stock     (5)   (5) Common Stock   134082   (5) $0.00   I   (2) By Kleiner Perkins Caufield & Byers XII, LLC   (2)
Series B Preferred Stock     (5)   (5) Common Stock   2563   (5) $0.00   I   (3) By KPCB XII Founders Fund, LLC   (3)
Series C Preferred Stock     (4)   (4) Common Stock   14517   (4) $0.00   I   (1) By Clarus, LLC   (1)
Series C Preferred Stock     (4)   (4) Common Stock   375705   (4) $0.00   I   (2) By Kleiner Perkins Caufield & Byers XII, LLC   (2)
Series C Preferred Stock     (4)   (4) Common Stock   4784   (4) $0.00   I   (3) By KPCB XII Founders Fund, LLC   (3)

Explanation of Responses:
( 1)  The reporting person is the manager of Clarus, LLC. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee" for the account of entities affiliated with Kleiner Perkins Caufield & Byers and others. KPCB Holdings, Inc. has no voting, dispositive or pecuniary interest in any such shares.
( 2)  The General Partner of Kleiner Perkins Caufield & Byers XII, LLC is KPCB XII Associates, LLC, of which the reporting person is a managing member. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee" for the account of entities affiliated with Kleiner Perkins Caufield & Byers and others. KPCB Holdings, Inc. has no voting, dispositive or pecuniary interest in any such shares.
( 3)  The General Partner of KPCB XII Founders Fund, LLC is KPCB XII Associates, LLC, of which the reporting person is a managing member. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee" for the account of entities affiliated with Kleiner Perkins Caufield & Byers and others. KPCB Holdings, Inc. has no voting, dispositive or pecuniary interest in any such shares.
( 4)  Upon completion of the Issuer's initial public offering, each outstanding share of Series A Preferred Stock and Series C Preferred Stock will be automatically converted into one share of the Issuer's Common Stock. The Series A Preferred Stock and Series C Preferred Stock have no expiration date.
( 5)  Upon completion of the Issuer's initial public offering, each outstanding share of Series B Preferred Stock will be automatically converted into 1.118 shares of the Issuer's Common Stock. The number of shares of underlying Common Stock reported in Column 3 does not reflect this automatic conversion. The Series B Preferred Stock has no expiration date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
DOERR L JOHN
C/O KLEINER PERKINS CAUFIELD & BYERS
2750 SAND HILL ROAD
MENLO PARK, CA 94025
X



Signatures
/s/ L. John Doerr by Tamara Tompkins, Attorney-in-Fact 9/27/2010
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Exhibit 24



                                POWER OF ATTORNEY

        KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and
appoints Jeryl Hilleman and Tamara Tompkins, each with power to act without the
other, his or her true and lawful attorney-in-fact to:

        (1)     execute for and on behalf of the undersigned, in the
                undersigned's capacity as a representative of Amyris, Inc. (the
                "Company"), any and all Forms 3, 4 and 5 reports required to be
                filed by the undersigned in accordance with Section 16(a) of the
                Securities Act of 1934 and the rules and regulations thereunder
                with respect to transactions in Company securities;

        (2)     do and perform any and all acts for and on behalf of the
                undersigned which may be necessary or desirable to complete and
                execute any such Forms 3, 4 and 5 and timely file such forms
                with the United States Securities and Exchange Commission and
                any stock exchange or similar authority; and

        (3)     take any other action which, in the opinion of such
                attorney-in-fact, may be of benefit to, in the best interest of,
                or legally required by, the undersigned in connection with the
                foregoing powers.

        The undersigned hereby grants to such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite, or
proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that any such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that each such attorney-in-fact, in
serving in such capacity at the request of the undersigned, is not assuming, nor
is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Act of 1934.

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 or 5 with respect to the
undersigned's holdings of and transactions in Company securities, unless earlier
revoked by the undersigned in a signed writing delivered to any of the foregoing
attorneys-in-fact.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 16th day of September, 2010.

                                    By:   /s/ John Doerr
                                          -------------------------------------
                                          (signature)

                                    Name: John Doerr
                                          -------------------------------------
                                          (print name)